Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verveld

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Immunologic Research|January 1, 1992
Immunotherapy through the IL-2 receptorH A Verheul, M Verveld, E S Bos
Immunopharmacology and Immunotoxicology|February 1, 1995
Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD miceH A Verheul, M Verveld, S Hoefakker, et al.
European Journal of Immunology|December 1, 1988
Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cellsW M Kast, E Van Twuyver, R J Mooijaart, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Immunologic Research|January 1, 1992
Immunotherapy through the IL-2 receptorH A Verheul, M Verveld, E S Bos
Immunopharmacology and Immunotoxicology|February 1, 1995
Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD miceH A Verheul, M Verveld, S Hoefakker, et al.
European Journal of Immunology|December 1, 1988
Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cellsW M Kast, E Van Twuyver, R J Mooijaart, et al.
Pageof 1